Can a simple ultrasound score predict dangerous placental complications?
NCT ID NCT07755709
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This trial is testing whether a new ultrasound scoring system can accurately predict the severity of placenta accreta spectrum (PAS), a condition where the placenta grows too deeply into the uterine wall. The study will enroll 50 pregnant women with placenta previa and a history of uterine surgery, and compare ultrasound scores with actual findings during cesarean delivery. The goal is to see if the score can predict the need for hysterectomy, bladder injury, blood transfusions, and ICU admission, potentially improving surgical planning and outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A novel ultrasound scoring system
- What this could lead to
- If successful, this scoring system could help doctors predict the severity of placenta accreta before delivery, potentially reducing complications by guiding surgical planning.
- What could go wrong
- This is a small, early-stage study, and the scoring system may not prove accurate enough for widespread use. It is also limited to a specific group of pregnant women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pregnant women aged 18 to 45 years. Gestational age ≥28 weeks at the time of enrollment. Diagnosed Placenta Previa with a history of: One or more previous cesarean sections Uterine scarring due to previous surgery as (myomectomy, D\&C, Metroplasty).
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant women aged 18 to 45 years. * Gestational age ≥28 weeks at the time of enrollment. * Diagnosed Placenta Previa with a history of: * One or more previous cesarean sections * Uterine scarring due to previous surgery as (myomectomy, D\&C, Metroplasty). * Singleton pregnancy. Exclusion Criteria: * Women with multiple pregnancies (twins, triplets, etc.). * Pregnancies complicated by acute medical conditions (e.g., heart failure, uncontrolled diabetes). * Prior history of Blood diseases. (other than those related to pregnancy). * Women who refuse to participate or withdraw consent during the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Placenta accreta, third trimester are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.